PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial.
2015 ◽
Vol 33
(15_suppl)
◽
pp. 3541-3541
◽
Keyword(s):
Phase Ii
◽